Category | Big pharma

Pfizer creates breaking news with Allergan purchase

Posted on 23 November 2015

US drugs giant Pfizer has sealed a deal to buy Botox-maker Allergan for $160bn (£106bn) in what is the biggest pharmaceuticals deal in history.

Tags: , , ,

When de-risking, relationships matter: How using key strategies can get you to your next innovative partnership

Posted on 10 August 2015

An interview with Richard Brudnick, Senior VP, Corporate Development, Biogen De-risking has evolved from literature searches to the cultivation of many wide-ranging relationships throughout the life sciences strata, according to Richard Brudnick, Senior VP, Corporate Development at Biogen. In a recent interview, Brudnick outlined key strategies to accessing innovation and “de-risking” risk through collaboration.

Tags: , , , ,

Boehringer Ingelheim acquires Pharmaxis’ anti-inflammatory candidate

Posted on 18 May 2015

Boehringer Ingelheim exercises option and acquires global ownership of Pharmaxis’ investigational anti-inflammatory drug candidate PXS4728A, including associated intellectual property rights.

Tags: ,

Endo International acquires Par Pharmaceutical

Posted on 18 May 2015

Endo International and Par Pharmaceutical Holdings have entered into a definitive agreement under which Endo will acquire privately-held Par from TPG in a transaction valued at $8.05 billion, including assumption of Par debt.

Tags: , ,

Transition Therapeutics licenses drug candidate from Eli Lilly

Posted on 06 May 2015

Transition Therapeutics announced its wholly-owned subsidiary, Transition Therapeutics Ireland Limited, has exclusively licensed worldwide rights to a novel small molecule drug candidate (“TT701”) from Eli Lilly and Company.

Tags: ,

EMD Serono and Pfizer in co-promotion agreement for Xalkori

Posted on 06 May 2015

EMD Serono has begun co-promoting Pfizer’s anaplastic lymphoma kinase (ALK) inhibitor XALKORI (crizotinib) as part of its global strategic alliance with Pfizer.

Tags: ,

Pfizer in collaboration agreement for lupus study

Posted on 05 May 2015

23andMe announced the launch of the Lupus Research Study in collaboration with Pfizer.

Tags: ,

Bayer and Isis in ISIS-FXIRx licensing pact

Posted on 05 May 2015

Bayer HealthCare has entered into an exclusive license agreement with Isis Pharmaceuticals on ISIS-FXIRx

Tags: , ,

Roche and 4D Molecular partner for AAV vectors

Posted on 30 April 2015

4D Molecular Therapeutics announced a collaboration and license agreement with Roche to discover and develop optimized next-generation AAV vectors

Tags: , ,

Celgene acquires Quanticel Pharmaceuticals

Posted on 28 April 2015

Celgene and Quanticel Pharmaceuticals announced a definitive share purchase agreement under which Celgene will acquire Quanticel

Tags: , , ,